Contents: Hemophilia treatment past and present
Gene transfer for genetic disease
Viruses engineered to deliver genes
Gene therapy using integrating vectors
Adeno-associated virus (AAV) structure and composition
AAV-Factor IX vectors
AAV-mediated gene transfer for hemophilia
Risk of germline transmission
Peptide library based on AAV and Factor IX
Transaminitis and liver enzymes
Neutralizing antibodies to AAV
Self-complementary DNA and Factor IX synthesis
Strategies to overcome immunity to AAV
Use of empty capsids.